10-Q Filing

AGILON HEALTH, INC. CIK: 1831097 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-007884`
Period End Date	20220331
Filing Date	20220505
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	agl-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 46 Cash Flow Statement 52 Stockholders Equity 18

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.02B	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$14.78M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$14.47M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$293.41M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$571.87M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$18.97M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$19.85M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.63B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.37B	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.16M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	405.73M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.53M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	400.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	405.73M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.40M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$53.71M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Assets	`Assets`	$1.59B	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Assets	`Assets`	$1.86B	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$119.50M	USD	Point-in-time
Liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Liabilities	`Liabilities`	$743.73M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$112.96M	USD	Point-in-time
Total assets	`Assets`	$1.59B	USD	Point-in-time
Total assets	`Assets`	$1.86B	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$472.32M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$239.01M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$112.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$133.14M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$610.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$356.96M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$42.17M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$43.40M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$94.30M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$91.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$743.73M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 405,727 and 400,095 shares issued and outstanding, respectively	`CommonStockValue`	$4.06M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 405,727 and 400,095 shares issued and outstanding, respectively	`CommonStockValue`	$4.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.06B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.05B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-956.45M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-957.68M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.11B	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.09B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-300.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-375.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.59B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.86B	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$1.47M	USD	1 Quarter
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$3.97M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$413.10M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$653.45M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$360.35M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$566.21M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$44.77M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$23.66M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $3,970 and $1,472, respectively)	`GeneralAndAdministrativeExpense`	$39.83M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $3,970 and $1,472, respectively)	`GeneralAndAdministrativeExpense`	$37.78M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.37M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.43M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$425.22M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$654.19M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-12.12M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-743.00K	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$1.34M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$2.27M	USD	1 Quarter
Interest expense	`InterestExpense`	$871.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.94M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.72M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$655.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$16.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-71.00K	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-13.74M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$726.00K	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.35M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$429.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$64.00K	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.42M	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$429.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-15.15M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.16M	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-73.00K	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-75.00K	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$1.23M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-15.08M	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.04	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	-	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.01	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	325.66M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	401.96M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	424.06M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	325.66M	shares	1 Quarter

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-15.15M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.16M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.48M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.37M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.97M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.47M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.19M	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.03M	USD	1 Quarter
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.00K	USD	1 Quarter
Other noncash items	`OtherNoncashIncomeExpense`	$-1.76M	USD	1 Quarter
Other noncash items	`OtherNoncashIncomeExpense`	$-556.00K	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$30.25M	USD	1 Quarter
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$33.58M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-40.83M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.23M	USD	1 Quarter
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$178.00K	USD	1 Quarter
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.05M	USD	1 Quarter
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$1.00M	USD	1 Quarter
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$3.99M	USD	1 Quarter
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$1.20M	USD	1 Quarter
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$4.50M	USD	1 Quarter
Proceeds from repayment of loans receivable and other	`ProceedsFromCollectionOfLoansReceivable`	$183.00K	USD	1 Quarter
Proceeds from repayment of loans receivable and other	`ProceedsFromCollectionOfLoansReceivable`	-	USD	1 Quarter
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-3.71M	USD	1 Quarter
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$500.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.87M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.07M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$165.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$14.76M	USD	1 Quarter
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	1 Quarter
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.25M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$68.65M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.22M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.51M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$30.30M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-19.60M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-18.60M	USD	1 Quarter
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$1.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$119.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$1.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$119.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$1.05B	USD	Point-in-time

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	405.73M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-15.15M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.16M	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$165.00K	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$14.76M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.97M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.47M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	405.73M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.